Allergy

The prevalence of allergies has been inexorably rising for a number of years to the point that 15-20% of the population now suffers from some form of allergy. Since the discovery of IgE in 1967, testing for these conditions has become more reliable with the development of a broad range of serum-based tests (specific IgE and IgG, constitutionally expressed and induced mediators, cytokines) and cell-based tests for a variety of effector cells (basophils, eosinophils, lymphocytes).

TESTING

Eurofins Biomnis offers assays for specific IgEs directed against more than 400 different allergens. We also assay specific IgG and IgG 4 to monitor desensitisation protocols (notably for hypersensitivity to hymenopteran venom) and can test cells to measure the production of various mediators such as histamine and leukotrienes.